United Kingdom · Question · Written question
UIN 9074
Tixagevimab/cilgavimab
Original
Introduced
25 May 2022
Last action
21 June 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 June 2022
Summary
To ask the Secretary of State for Health and Social Care, on what date the UK Health Security Agency plans to complete testing on Evusheld’s efficacy against the omicron variant of covid-19; and what steps his Department plans to take to notify immunocomp
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 May 2022
Written question
To ask the Secretary of State for Health and Social Care, on what date the UK Health Security Agency plans to complete testing on Evusheld’s efficacy against the omicron variant of covid-19; and what steps his Department plans to take to notify immunocomp
Source: Commons
21 June 2022
Answer
AstraZeneca commissioned the UK Health Security Agency (UKHSA) to undertake testing on the effectiveness of Evusheld against the Omicron variants and initial data for the BA.1 and BA.2 variants has been shared. However, AstraZeneca has not commissioned th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-05-25/9074
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1465756
- uk · wq-1465756 · source updated 21 June 2022